AMYT.L Share News (AMYT)
AMYT Share
AMYT Share
AMYT Share
AMYT Share
AMYT
AMYT Share
AMYT Broker
AMYT Directors
AMYT Financial
AMYT
AMYT Short
AMYT
(Sharecast News) - Biopharmaceutical company Amryt Pharma announced on Wednesday that it has received marketing authorisation approval from the Brazilian Health Regulatory Agency (ANVISA) for 'Lojuxta', or lomitapide.
Read more(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma has entered into agreements to raise $40m, it announced on Tuesday, to fund working capital as well as potential acquisitions and licence deals.
Read more
IN BRIEF: Amryt Pharma Posts Success From Filsuvez Trial
Read more(Sharecast News) - Biopharmaceutical company Amryt Pharma announced positive results from its pivotal phase 23 'EASE' trial of 'Filsuvez', or 'Oleogel-S10', previously 'AP101', on Thursday.
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read moreIN BRIEF: Amryt Pharma Signs Distribution Deal With Swixx Biopharma
Read more(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma announced the signing of a distribution agreement with Swixx BioPharma of Baar, Switzerland on Monday.
Read moreUK TRADING UPDATE SUMMARY: Mortgage Advice Bureau Launches Later Life
Read more(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma announced positive top-line results from its pivotal phase 3 'EASE' trial of 'Filsuvez' for the treatment of dystrophic and junctional epidermolysis bullosa on Wednesday.
Read moreUK WINNERS & LOSERS SUMMARY: Amryt Surges Nearly 50% On Trial Results
Read moreAmryt Pharma Shares Jump On Positive Third-Phase Filsuvez Trial Result
Read moreIN BRIEF: Amryt Lauds Nasdaq Global Listing "Milestone"
Read moreIN BRIEF: Amryt Pharma To List American Depository Shares In US
Read moreUK DIRECTOR DEALINGS SUMMARY: XP Power Chair In GBP3.6 Million Sale
Read moreUK DIRECTOR DEALINGS SUMMARY: Braveheart Investment CEO Cuts Stake
Read more
